Article ID,Publication Year,Reference,US$/QALY *,Ratio Description,PubMed ID,Target Population,Intervention Description,Title,Comparator Description,Impact
2017-01-24629,2017,Christensen 2017 Int J Circumpolar Health,Cost-Saving,"Decentralized screening VERSUS Centralized screening IN Healthy; Age- 41 to 64 years, >=65 years; Gender- Female; Country- Denmark.",28934900,"Healthy; Age- 41 to 64 years, >=65 years; Gender- Female; Country- Denmark.",Decentralized screening,Societal costs and effects of implementing population-based mammography screening in Greenland.,Centralized screening,SE
2017-01-24629,2017,Christensen 2017 Int J Circumpolar Health,Dominated,"Decentralized screening VERSUS Centralized screening IN Healthy; Age- 41 to 64 years, >=65 years; Gender- Female; Country- Denmark.",28934900,"Healthy; Age- 41 to 64 years, >=65 years; Gender- Female; Country- Denmark.",Decentralized screening,Societal costs and effects of implementing population-based mammography screening in Greenland.,Centralized screening,NW
2014-01-16901,2014,Pletcher 2014 Circ Cardiovasc Qual Outcomes,25000,Statin Treatment if coronary artery calcium (CAC) score>100 VERSUS None IN Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,24619318,Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,Statin Treatment if coronary artery calcium (CAC) score>100,Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.,None,NE
2014-01-16901,2014,Pletcher 2014 Circ Cardiovasc Qual Outcomes,70,Statin Treatment regardless of coronary artery calcium (CAC) score VERSUS None IN Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,24619318,Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,Statin Treatment regardless of coronary artery calcium (CAC) score,Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.,None,NE
2014-01-16901,2014,Pletcher 2014 Circ Cardiovasc Qual Outcomes,900000,Statin Treatment if coronary artery calcium (CAC) score>300 VERSUS None IN Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,24619318,Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,Statin Treatment if coronary artery calcium (CAC) score>300,Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.,None,NE
2014-01-16901,2014,Pletcher 2014 Circ Cardiovasc Qual Outcomes,Cost-Saving,Statin Treatment if coronary artery calcium (CAC) score >0 VERSUS None IN Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,24619318,Healthy; Age- 41 to 64 years; Gender- Female; Country- United States.,Statin Treatment if coronary artery calcium (CAC) score >0,Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis.,None,SE
2008-01-04125,2008,Newman 2008 Prev Cardiol,Dominated,"Combination treatment with simvastatin, captopril, hydrochlorthiazide and atenolol to prevent cardiovascular disease onset VERSUS No preventive treatment IN Men in the United States aged >55 years without cardiovascular disease, hypertension or dyslipidemia",18174790,"Men in the United States aged >55 years without cardiovascular disease, hypertension or dyslipidemia","Combination treatment with simvastatin, captopril, hydrochlorthiazide and atenolol to prevent cardiovascular disease onset",Combination polypharmacy for cardiovascular disease prevention in men: a decision analysis and cost-effectiveness model.,No preventive treatment,NW
1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
